| Nextmol | ES | series-b+ | $2.7M |
| nextProtein | FR | series-b+ | $19.4M |
| Nimble Robotics | US | series-b+ | $250.0M |
| NIRSENSE, INC | US | unknown | $2.6M |
| Nitrocapt | SE | unknown | $2.7M |
| NLIGN ANALYTICS, INC. | US | unknown | $1.8M |
| NOBLE GAS SYSTEMS INC. | US | unknown | $1.9M |
| Nodes & Links | GB | seed | $12.0M |
| NOKOMIS INC | US | unknown | $4.3M |
| Nomadar Corp. | US | unknown | $3.8M |
| Nomagic | PL | series-b+ | $74.0M |
| NONLINEAR MATERIALS CORP | US | unknown | $1.8M |
| Noria Energy Holdings Llc | US | unknown | $1.1M |
| Nostopharma LLC | US | series-b+ | $1.0M |
| NOVASTERILIS, INC. | US | unknown | $1.8M |
| NOVATEUR RESEARCH SOLUTIONS LLC | US | unknown | $1.8M |
| NOVEL ENGINEERING INC. | US | unknown | $1.2M |
| NOVIAN HEALTH INC. | US | unknown | $4.2M |
| Novobiom | BE | unknown | $2.7M |
| NOVOMEDIX LLC | US | unknown | $3.0M |
| NPHarvest | FI | seed | $2.4M |
| NPS RADAR, LLC | US | unknown | $1.8M |
| Nuance Labs, Inc. | US | unknown | $9.8M |
| Nuburu, Inc. | US | unknown | $23.3M |
| Nuclein, LLC | US | unknown | $19.1M |
| Nusano | US | series-b+ | $115.0M |
| NUSHORES BIOSCIENCES LLC | US | unknown | $3.0M |
| Nusirt Sciences, INC. | US | series-b+ | $1.1M |
| Nutropy | FR | seed | $7.6M |
| Nyobolt | GB | series-b+ | $28.1M |
| NYTRICX INC | US | unknown | $2.3M |
| OCEANIT LABORATORIES INC | US | unknown | $4.1M |
| Ochre Bio | GB | series-b+ | $75.0M |
| Octavia Technologies, Inc. | US | unknown | $3.5M |
| OLEDWORKS LLC | US | unknown | $2.0M |
| Oligofeed | FR | series-b+ | $2.7M |
| OLIGOMERIX INC | US | unknown | $3.0M |
| OMBRA LLC | US | unknown | $2.0M |
| Omcare Inc. | US | unknown | $2.8M |
| OMNI FED LLC | US | unknown | $2.6M |
| Onc.AI, Inc. | US | unknown | $2.0M |
| Oncomatryx Biopharma | ES | series-b+ | $2.7M |
| ONENAV, INC | US | unknown | $1.2M |
| ONERADIO CORPORATION | US | unknown | $1.2M |
| Ontic | US | series-b+ | $400.0M |
| OPCONDYS INC | US | unknown | $1.5M |
| OPe, LLC | US | unknown | $6.3M |
| OpiAID, LLC | US | unknown | $1.3M |
| OpsMill | FR | series-a | $14.0M |
| Optics11 | NL | series-b+ | $32.4M |
| Optimeos Life Sciences, Inc. | US | unknown | $1.0M |
| OPTIMIZATION TECHNOLOGIES, INC. | US | unknown | $2.0M |
| Optiml | CH | pre-seed | $3.8M |
| OpZira, Inc. | US | unknown | $1.1M |
| Oraliva, INC. | US | series-b+ | $1.2M |
| Orbital Paradigm | ES | pre-seed | $1.6M |
| Orby AI | US | series-a | $30.0M |
| Orca AI | GB | series-a | $40.0M |
| OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. | US | unknown | $1.9M |
| Oriole Networks | GB | series-a | $35.0M |
| ORPHAGEN PHARMACEUTICALS, INC. | US | unknown | $1.7M |
| Ortivity | DE | series-b+ | $216.0M |
| Osapiens | DE | series-b+ | $120.0M |
| Osmos X | FR | unknown | $4.0M |
| OSSIUM HEALTH INC | US | unknown | $1.4M |
| OTS ACQUISITION GROUP, LLC | US | unknown | $1.5M |
| Ouro Medicines | US | series-a | $120.0M |
| OUTERLINK CORP | US | unknown | $6.5M |
| Outlook Therapeutics, Inc. | US | unknown | $5.0M |
| OUTPOST TECHNOLOGIES, INC. | US | unknown | $1.9M |
| Ovelle Bio Corp. | US | unknown | $7.0M |
| Overmatch, Inc. | US | unknown | $3.5M |
| Ovoko | LT | series-b+ | $32.4M |
| Oxford Quantum Circuits | GB | series-b+ | $330.2M |
| OxfordQuantumCircuits | GB | series-b+ | $330.2M |
| Oxolife | ES | unknown | $2.7M |
| P & J ROBINSON CORP | US | unknown | $2.0M |
| PAI LIFE SCIENCES INC | US | unknown | $1.4M |
| PanGIA Biotech | US | unknown | $1.6M |
| PANTA | GB | seed | $3.7M |
| Paragraf | GB | series-b+ | $129.6M |
| PARENTHETIC, LLC | US | unknown | $4.1M |
| PARMEDICS, INC | US | unknown | $1.7M |
| PARRY LABS, LLC | US | unknown | $2.5M |
| PAXAURIS LLC | US | unknown | $1.5M |
| Paymentology | GB | series-b+ | $250.0M |
| Payt | NL | series-b+ | $59.4M |
| Peak Quantum | DE | pre-seed | $5.4M |
| Pear Health Labs, Inc. | US | unknown | $1.9M |
| Pearl Bio | US | series-a | $1.0M |
| Pearl Diagnostics, Inc. | US | unknown | $11.2M |
| Pearl Diagnostics, Inc. | US | unknown | $11.2M |
| PECOS WIND POWER INC | US | unknown | $2.5M |
| Pelage Pharmaceuticals | US | series-b+ | $120.0M |
| PENDERIA TECHNOLOGIES, INC. | US | unknown | $1.7M |
| Pentera | US | series-b+ | $250.0M |
| Peptomyc | ES | unknown | $2.7M |
| Performance Systems Development Of New York Llc | US | unknown | $1.1M |
| PERFUSION MEDICAL LLC | US | unknown | $3.0M |
| Perpetual Next | NL | series-b+ | $302.4M |